JP2001526224A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001526224A5 JP2001526224A5 JP2000525105A JP2000525105A JP2001526224A5 JP 2001526224 A5 JP2001526224 A5 JP 2001526224A5 JP 2000525105 A JP2000525105 A JP 2000525105A JP 2000525105 A JP2000525105 A JP 2000525105A JP 2001526224 A5 JP2001526224 A5 JP 2001526224A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cancer
- fpt inhibitor
- substituted
- proliferative disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99602797A | 1997-12-22 | 1997-12-22 | |
| US08/996,027 | 1997-12-22 | ||
| US14352998A | 1998-08-28 | 1998-08-28 | |
| US09/143,529 | 1998-08-28 | ||
| US18196998A | 1998-10-29 | 1998-10-29 | |
| US09/181,969 | 1998-10-29 | ||
| PCT/US1998/026224 WO1999032114A1 (en) | 1997-12-22 | 1998-12-21 | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001526224A JP2001526224A (ja) | 2001-12-18 |
| JP2001526224A5 true JP2001526224A5 (https=) | 2006-02-09 |
| JP4502503B2 JP4502503B2 (ja) | 2010-07-14 |
Family
ID=27385940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000525105A Expired - Fee Related JP4502503B2 (ja) | 1997-12-22 | 1998-12-21 | 増殖性の疾患を処置するためのベンゾシクロヘプタピリジン化合物および抗腫瘍剤の組合せ |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1041985B1 (https=) |
| JP (1) | JP4502503B2 (https=) |
| KR (1) | KR100700907B1 (https=) |
| CN (1) | CN1129431C (https=) |
| AR (1) | AR017440A1 (https=) |
| AT (1) | ATE317697T1 (https=) |
| AU (1) | AU756762B2 (https=) |
| BR (1) | BR9814419A (https=) |
| CA (1) | CA2315693C (https=) |
| CL (1) | CL2007001889A1 (https=) |
| CO (1) | CO5080764A1 (https=) |
| CZ (1) | CZ298511B6 (https=) |
| DE (1) | DE69833509T2 (https=) |
| DK (1) | DK1041985T3 (https=) |
| ES (1) | ES2255196T3 (https=) |
| HU (1) | HUP0102473A3 (https=) |
| IL (1) | IL136462A0 (https=) |
| MY (1) | MY137303A (https=) |
| NO (1) | NO326832B1 (https=) |
| NZ (1) | NZ504928A (https=) |
| PE (1) | PE20000042A1 (https=) |
| PT (1) | PT1041985E (https=) |
| SK (1) | SK285584B6 (https=) |
| TW (1) | TW581763B (https=) |
| WO (1) | WO1999032114A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2787327B1 (fr) * | 1998-12-21 | 2003-01-17 | Aventis Pharma Sa | Compositions contenant des inhibiteurs de farnesyle transferase |
| CZ20021550A3 (cs) * | 1999-11-09 | 2003-02-12 | Societe De Conseils De Recherches Et D'application | Produkt zahrnující inhibitor transdukce signálů heterotrimerického G proteinu kombinovaný s jiným protirakovinným činidlem pro terapeutické použití v léčbě rakoviny |
| WO2001045740A2 (en) * | 1999-12-22 | 2001-06-28 | The Government Of The United States, Department Of Health And Human Services | Compositions and methods for treatment of breast cancer |
| US20030027808A1 (en) * | 2000-02-29 | 2003-02-06 | Palmer Peter Albert | Farnesyl protein transferase inhibitor combinations with platinum compounds |
| EP1261343A2 (en) * | 2000-02-29 | 2002-12-04 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives |
| US20030078281A1 (en) * | 2000-02-29 | 2003-04-24 | Rybak Mary Ellen Margaret | Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents |
| EP1267871A2 (en) * | 2000-02-29 | 2003-01-02 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives |
| WO2001064196A2 (en) * | 2000-02-29 | 2001-09-07 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with vinca alkaloids |
| AU2001244167A1 (en) * | 2000-02-29 | 2001-09-12 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
| TWI310684B (en) | 2000-03-27 | 2009-06-11 | Bristol Myers Squibb Co | Synergistic pharmaceutical kits for treating cancer |
| WO2002056884A2 (en) * | 2001-01-22 | 2002-07-25 | Schering Corporation | Treatment of malaria with farnesyl protein transferase inhibitors |
| JP4969016B2 (ja) * | 2001-02-15 | 2012-07-04 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗エストロゲン剤とファルネシルプロテイントランスフェラーゼ阻害剤の組み合わせ物 |
| CN1617755A (zh) * | 2001-11-30 | 2005-05-18 | 先灵公司 | 法尼基蛋白转移酶抑制剂和其它抗肿瘤剂联合使用在制备抗癌症的药物中的应用 |
| CA2468996A1 (en) * | 2001-12-03 | 2003-06-12 | Schering Corporation | Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer |
| WO2008022535A1 (fr) * | 2006-08-09 | 2008-02-28 | Tian Jin Tasly Group Co., Ltd. | Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique |
| CN105198758A (zh) * | 2015-09-22 | 2015-12-30 | 湖南大学 | 一种高纯度(z)-他莫昔酚的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047246A (en) * | 1988-09-09 | 1991-09-10 | Bristol-Myers Company | Direct compression cyclophosphamide tablet |
| WO1992011034A1 (en) * | 1990-12-18 | 1992-07-09 | The Wellcome Foundation Limited | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| JP2767176B2 (ja) * | 1992-12-15 | 1998-06-18 | 大塚製薬株式会社 | 抗癌剤 |
| US5637688A (en) * | 1994-12-13 | 1997-06-10 | Eli Lilly And Company | Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride |
| DE69635114T2 (de) * | 1995-08-09 | 2006-03-02 | Banyu Pharmaceutical Co., Ltd. | Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids |
| IL125062A (en) * | 1995-12-22 | 2003-11-23 | Schering Corp | Tricyclic amides and pharmaceutical compositions containing them for inhibition of g-protein function and for treatment of proliferative diseases |
| CN1304058C (zh) * | 1996-03-12 | 2007-03-14 | Pg－Txl有限公司 | 水溶性紫杉醇产品 |
| EP0959883A4 (en) * | 1996-04-03 | 2001-05-09 | Merck & Co Inc | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE |
| US20020034725A1 (en) * | 1996-04-15 | 2002-03-21 | W. Gillies Mckenna | Sensitization of cells to radiation and and chemotherapy |
| CA2251955A1 (en) * | 1996-04-18 | 1997-10-23 | Nancy E. Kohl | A method of treating cancer |
| EP0934270A1 (en) * | 1996-05-30 | 1999-08-11 | Merck & Co., Inc. | A method of treating cancer |
| US6337992B1 (en) * | 1997-01-29 | 2002-01-08 | Philips Medical Systems Technologies Ltd. | Predictive bolus tracking |
| IL131447A0 (en) * | 1997-02-18 | 2001-01-28 | Canji Inc | Combined tumor supressor gene therapy and chemotherapy in the treatment of neoplasms |
-
1998
- 1998-12-21 DK DK98963829T patent/DK1041985T3/da active
- 1998-12-21 PE PE1998001263A patent/PE20000042A1/es not_active Application Discontinuation
- 1998-12-21 SK SK898-2000A patent/SK285584B6/sk not_active IP Right Cessation
- 1998-12-21 EP EP98963829A patent/EP1041985B1/en not_active Expired - Lifetime
- 1998-12-21 AR ARP980106565A patent/AR017440A1/es unknown
- 1998-12-21 HU HU0102473A patent/HUP0102473A3/hu unknown
- 1998-12-21 KR KR1020007006938A patent/KR100700907B1/ko not_active Expired - Fee Related
- 1998-12-21 DE DE69833509T patent/DE69833509T2/de not_active Expired - Lifetime
- 1998-12-21 CA CA2315693A patent/CA2315693C/en not_active Expired - Fee Related
- 1998-12-21 TW TW087121355A patent/TW581763B/zh not_active IP Right Cessation
- 1998-12-21 AU AU19072/99A patent/AU756762B2/en not_active Ceased
- 1998-12-21 WO PCT/US1998/026224 patent/WO1999032114A1/en not_active Ceased
- 1998-12-21 CN CN98813742A patent/CN1129431C/zh not_active Expired - Fee Related
- 1998-12-21 AT AT98963829T patent/ATE317697T1/de not_active IP Right Cessation
- 1998-12-21 MY MYPI98005809A patent/MY137303A/en unknown
- 1998-12-21 NZ NZ504928A patent/NZ504928A/xx unknown
- 1998-12-21 CZ CZ20002236A patent/CZ298511B6/cs not_active IP Right Cessation
- 1998-12-21 CO CO98075842A patent/CO5080764A1/es unknown
- 1998-12-21 ES ES98963829T patent/ES2255196T3/es not_active Expired - Lifetime
- 1998-12-21 PT PT98963829T patent/PT1041985E/pt unknown
- 1998-12-21 JP JP2000525105A patent/JP4502503B2/ja not_active Expired - Fee Related
- 1998-12-21 IL IL13646298A patent/IL136462A0/xx unknown
- 1998-12-21 BR BR9814419-7A patent/BR9814419A/pt not_active Application Discontinuation
-
2000
- 2000-06-21 NO NO20003229A patent/NO326832B1/no not_active IP Right Cessation
-
2007
- 2007-06-27 CL CL2007001889A patent/CL2007001889A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001526224A5 (https=) | ||
| JP2003529540A5 (https=) | ||
| CA2315693A1 (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases | |
| AU2002248542B9 (en) | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases | |
| CA2665539A1 (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| CA2665543A1 (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| RU2008117295A (ru) | Новые пиразолопиримидины как ингибиторы циклинзависимых киназ | |
| US7008936B2 (en) | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases | |
| CA2499756A1 (en) | Imidazopyrazines as cyclin dependent kinase inhibitors | |
| HRP20110245T1 (hr) | Derivati pirazolopirimidina kao inhibitori o ciklinu ovisne kinaze | |
| MXPA05003119A (es) | Nuevas imidazopirazinas como inhibidores de cinasas dependientes de ciclinas. | |
| CA2497440A1 (en) | Pyrazolopyrimidines as cyclin-dependent kinase inhibitors | |
| RU2008122967A (ru) | Имидазопиразины в качестве ингибиторов протеинкиназ | |
| CA2497444A1 (en) | Pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| PA8444201A1 (es) | Derivados ciclicos de sulfona | |
| DE60113809D1 (de) | Pharmazeutische kombination aus mikronisiertem drospirenon und einen estrogen für die hormonersatztherapie | |
| AU2002248542A1 (en) | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases | |
| IT1245889B (it) | Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari. | |
| CA2497539A1 (en) | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors | |
| CA2557184A1 (en) | Pyrazolotriazines as kinase inhibitors | |
| JP2004513885A5 (https=) | ||
| CA2499593A1 (en) | Pyrazolopyridines as cyclin dependent kinase inhibitors | |
| Tetef et al. | 5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial | |
| US7105560B1 (en) | Use of etodolac in the treatment of multiple myeloma | |
| WO2025061140A1 (zh) | 治疗非霍奇金淋巴瘤的药物组合及其用途 |